Literature DB >> 19852576

Characterization of CTNS mutations in Arab patients with cystinosis.

Mohammed A Aldahmesh1, Amal Humeidan, Hamad A Almojalli, Arif O Khan, Mohammed Rajab, Abbas A AL-Abbad, Brian F Meyer, Fowzan S Alkuraya.   

Abstract

BACKGROUND: Cystinosis is an autosomal recessive disease characterized by impaired transport of free cystine out of lysosomes with resulting renal and ophthalmic manifestations. Mutations in CTNS, encoding cystinosin, are the only known cause of this autosomal recessive disorder with more than 85 different mutations described so far.
PURPOSE: To identify CTNS mutations in Arab cystinosis patients.
METHODS: In this study, we have analyzed the mutational spectrum of CTNS in a population of 21 patients from 13 families of Arab origin. The entire coding region and flanking intronic regions of CTNS were analyzed by direct sequencing.
RESULTS: Eight mutations were identified, four of which are novel (c.530A>G, c.681G>A, 1013T>G, and c.1018_1041del).
CONCLUSION: These alleles will provide the basis for routine molecular diagnosis of cystinosis in the region.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19852576     DOI: 10.3109/13816810903200953

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  12 in total

1.  Infantile Nephropathic Cystinosis: A Novel CTNS Mutation.

Authors:  Hakan Doneray; Mohammed Aldahmesh; Gulsah Yilmaz; Emine Cinici; Zerrin Orbak
Journal:  Eurasian J Med       Date:  2017-06

2.  Molecular Analysis of the CTNS Gene in Indians with Nephropathic Cystinosis.

Authors:  Anup Arunrao Deshpande; Rajan Ravichandran; Anand Kumar Bachhawat
Journal:  Indian J Pediatr       Date:  2016-11-25       Impact factor: 1.967

3.  Nephropathic Cystinosis: First reported case in Oman.

Authors:  Dana Al-Nabhani; Mohammed El-Naggari; Rana Al-Sinawi; Alexander P Chacko; Anuradha Ganesh; Ibtisam El Nour
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

Review 4.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

5.  The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis.

Authors:  Rezan Topaloglu; Bora Gulhan; Mihriban İnözü; Nur Canpolat; Alev Yilmaz; Aytül Noyan; İsmail Dursun; İbrahim Gökçe; Metin Kaya Gürgöze; Nurver Akinci; Esra Baskin; Erkin Serdaroğlu; Beltinge Demircioğlu Kiliç; Selçuk Yüksel; Duygu Övünç Hacihamdioğlu; Emine Korkmaz; Mutlu Hayran; Fatih Ozaltin
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

6.  Genetic basis of cystinosis in Turkish patients: a single-center experience.

Authors:  Rezan Topaloglu; Thierry Vilboux; Turgay Coskun; Fatih Ozaltin; Brad Tinloy; Meral Gunay-Aygun; Aysin Bakkaloglu; Nesrin Besbas; Lambert van den Heuvel; Robert Kleta; William A Gahl
Journal:  Pediatr Nephrol       Date:  2011-07-24       Impact factor: 3.714

7.  Clinical and genetic characteristics of Tunisian children with infantile nephropathic cystinosis.

Authors:  Mariem El Younsi; Médiha Trabelsi; Sandra Ben Youssef; Inès Ouertani; Yousra Hammi; Ahlem Achour; Faouzi Maazoul; Maher Kharrat; Tahar Gargah; Ridha M'rad
Journal:  Pediatr Nephrol       Date:  2022-04-20       Impact factor: 3.714

8.  Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis.

Authors:  Neveen A Soliman; Mohamed A Elmonem; Lambertus van den Heuvel; Rehab H Abdel Hamid; Mohamed Gamal; Inge Bongaers; Sandrine Marie; Elena Levtchenko
Journal:  JIMD Rep       Date:  2014-01-25

Review 9.  Pediatric renal diseases in the Kingdom of Saudi Arabia.

Authors:  Jameela Abdulaziz Kari
Journal:  World J Pediatr       Date:  2012-08-12       Impact factor: 2.764

Review 10.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.

Authors:  Achini K Makuloluwa; Fatemeh Shams
Journal:  Clin Ophthalmol       Date:  2018-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.